Pharmacogenetics of immunosuppressants: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics (RNPGx)
Clinical guideline published by French National Network of Pharmacogenetics (RNPGx) on
The French National Network of Pharmacogenetics (RNPGx) focuses on integrating pharmacogenetic testing into clinical practice. It provides evidence-based guidelines for genetic testing, emphasizing the impact of genetic variants on drug efficacy and safety, and offers specific recommendations for various medical conditions.